Coverage
-
October 04, 2011
A New York federal judge on Tuesday reopened Pfizer Inc.'s patent infringement suit against Apotex Inc. over the company's plan to sell a generic version of the migraine drug Relpax, after a proposed settlement fell through.
1 other articles on this case.
View all »